recent publications

• academic article

  • Okano, A., Nakayama, A., Wu, K., Lindsey, E. A., Schammel, A. W., Feng, Y., Collins, K. C., Boger, D. L. Total syntheses and initial evaluation of [?[C(-S)NH]Tpg(4)]vancomycin, [?[C(-NH)NH]Tpg(4)]vancomycin, [?[CH2NH]Tpg(4)]vancomycin, and their (4-Chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics Journal of the American Chemical Society  2015 137:3693-3704  DOI:10.1021/jacs.5b01008  PMID:25750995  PMCID:PMC4376669
  • Lockner, J. W., Eubanks, L. M., Choi, J. L., Lively, J. M., Schlosburg, J. E., Collins, K. C., Globisch, D., Rosenfeld-Gunn, R. J., Wilson, I. A., Janda, K. D. Flagellin as carrier and adjuvant in cocaine vaccine development Molecular Pharmaceutics  2015 12:653-662  DOI:10.1021/mp500520r  PMID:25531528  PMCID:PMC4319694
  • Lockner, J. W., Lively, J. M., Collins, K. C., Vendruscolo, J. C. M., Azar, M. R., Janda, K. D. A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity Journal of Medicinal Chemistry  2015 58:1005-1011  DOI:10.1021/jm501625j  PMID:25493909
  • Nakayama, A., Okano, A., Feng, Y. Q., Collins, J. C., Collins, K. C., Walsh, C. T., Boger, D. L. Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate Organic Letters  2014 16:3572-3575  DOI:10.1021/ol501568t  PMID:24954524  PMCID:PMC4084835
  • Collins, K. C., Janda, K. D. Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse Bioconjugate Chemistry  2014 25:593-600  DOI:10.1021/bc500016k  PMID:24521489  PMCID:PMC3983143
  • Collins, K. C., Schlosburg, J. E., Lockner, J. W., Bremer, P. T., Ellis, B. A., Janda, K. D. Lipid tucaresol as an adjuvant for methamphetamine vaccine development Chemical Communications  2014 50:4079-4081  DOI:10.1039/c4cc00682h  PMID:24615284  PMCID:PMC4033696